A modified random assignment, six-month, double blind, parallel group comparison of lithium monotherapy versus the concurrent administration of lithium and divalproex for the prophylactic outpatient management of hypomania/mania in patients with rapid cycling bipolar disorder comorbid with substance abuse/dependence

Trial Profile

A modified random assignment, six-month, double blind, parallel group comparison of lithium monotherapy versus the concurrent administration of lithium and divalproex for the prophylactic outpatient management of hypomania/mania in patients with rapid cycling bipolar disorder comorbid with substance abuse/dependence

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Lithium (Primary) ; Valproate semisodium (Primary)
  • Indications Bipolar I disorders; Bipolar II disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Aug 2006 Status change
    • 07 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top